Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

C-reactive protein levels following acute myocardial infarction: effect of insulin infusion and tight glycemic control.

Wong VW, McLean M, Boyages SC, Cheung NW.

Diabetes Care. 2004 Dec;27(12):2971-3. No abstract available.

PMID:
15562216
3.

Insulin, glycemic control, and C-reactive protein during myocardial infarction.

Ceriello A.

Diabetes Care. 2004 Dec;27(12):3017-8. No abstract available.

PMID:
15562230
4.

Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target?

Chaudhuri A, Miller M, Nesto R, Rosenberg N, Dandona P.

Diabetes Care. 2007 Dec;30(12):3026-8. Epub 2007 Sep 11. No abstract available.

PMID:
17848612
6.

C-reactive protein in diabetic and nondiabetic patients with acute myocardial infarction.

Otter W, Winter M, Doering W, Standl E, Schnell O.

Diabetes Care. 2007 Dec;30(12):3080-2. Epub 2007 Sep 11. No abstract available.

PMID:
17848613
7.

Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.

Hollander P, Yu D, Chou HS.

Arch Intern Med. 2007 Jun 25;167(12):1284-90.

PMID:
17592102
8.

Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery.

Koskenkari JK, Kaukoranta PK, Rimpiläinen J, Vainionpää V, Ohtonen PP, Surcel HM, Juvonen T, Ala-Kokko TI.

Acta Anaesthesiol Scand. 2006 Sep;50(8):962-9.

PMID:
16923091
9.

Insulin infusion therapy for myocardial infarction.

Cheung NW, Wong VW, McLean M.

Expert Opin Pharmacother. 2006 Dec;7(18):2495-503. Review.

PMID:
17150004
10.

[Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].

Yang YM, Zhu J, Tan HQ, Liang Y, Zhang Y, Li Y, Li JD, Liu LS; National Coordinator Office of CREATE in China.

Zhonghua Yi Xue Za Zhi. 2008 Jul 8;88(26):1806-10. Chinese.

PMID:
19040013
11.
12.

Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control?

Steiropoulos P, Papanas N, Nena E, Tsara V, Fitili C, Tzouvelekis A, Christaki P, Maltezos E, Bouros D.

Sleep Med. 2009 Sep;10(8):887-91. doi: 10.1016/j.sleep.2008.10.004. Epub 2009 Feb 23.

PMID:
19231280
13.

Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.

Canale ML, Stroppa S, Caravelli P, Petronio AS, Mariotti R, Mariani M, Balbarini A, Barsotti A.

Coron Artery Dis. 2006 Dec;17(8):693-8.

PMID:
17119378
14.

Acute myocardial infarction, hyperglycemia, and insulin.

Dandona P, Chaudhuri A, Ghanim H.

J Am Coll Cardiol. 2009 Apr 21;53(16):1437-9. doi: 10.1016/j.jacc.2009.01.040. No abstract available.

15.
16.

Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.

Zhang HX, Zang YM, Huo JH, Liang SJ, Zhang HF, Wang YM, Fan Q, Guo WY, Wang HC, Gao F.

J Cardiovasc Pharmacol. 2006 Dec;48(6):306-13.

PMID:
17204910
17.

The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.

Celik T, Iyisoy A, Kursaklioglu H, Turhan H, Kilic S, Kose S, Amasyali B, Isik E.

Coron Artery Dis. 2005 Aug;16(5):293-9.

PMID:
16000887
18.

Does the pre-existing inflammation play a role in the increased C-reactive protein levels in acute myocardial infarction?

Celik T, Iyisoy A, Kursaklioglu H, Turhan H, Isik E.

Int J Cardiol. 2006 Sep 10;112(1):134-5; author reply 136-8. Epub 2006 May 2. No abstract available.

PMID:
16647767
19.

Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.

Yazici M, Demircan S, Durna K, Yasar E, Acar Z, Sahin M.

Am J Cardiol. 2005 Dec 1;96(11):1517-20. Epub 2005 Oct 14.

PMID:
16310433
20.

Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.

Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K, Beldekos DJ, Handanis SM, Mytas DZ, Karidis KS, Tselioti PG, Prekates AA, Ambrose JA.

Am J Cardiol. 2005 Aug 15;96(4):533-7.

PMID:
16098307

Supplemental Content

Support Center